Splose
PrivateLast Round
Series A
Feb 9, 2026
Total Funding Raised
$35.37M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Splose operates in Enterprise Software and is based in Adelaide. Its latest recorded funding round was a Series A round in February 2026.
Splose is a healthtech company that develops AI-powered practice management software designed to streamline administrative workflows for Allied Health and NDIS providers.
Sector
Enterprise Software
Verticals
Vertical SaaS, EHR & EMR, Workflow Automation, CRM
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Splose Comparables
Compare Splose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zanda | 88% | |
| Cliniko | 88% | |
| Halaxy | 86% |
For institutional investors. Book with your work email.
Splose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 9, 2026 | ||||
| Seed | Feb 21, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Splose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Equity Venture Partners | Series A, Seed |
| South Australia Government | Grant |
| Spectrum Equity | Series A |
| Equity Venture Partners | Series A, Seed |
| Athletic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Platform now serves over 28,000 practitioners.
- Jul 1, 2026
Trusted by over 25,000 Allied Health professionals.
For institutional investors. Book with your work email.
Splose Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Splose's valuation, stock price, and market status.
Is Splose a public or private company?
Splose is a private company.
What is the current stock price of Splose?
Splose is a private company, so its shares have no public market price. Caplight tracks Splose's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Splose worth (valuation)?
Valuation information for Splose is not publicly available.
Can I buy Splose stock?
Splose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Splose's last funding round?
Splose's most recent funding round was Series A on February 9, 2026.
Who are the main investors in Splose?
Key investors in Splose include Equity Venture Partners, Spectrum Equity, Equity Venture Partners.
Will Splose IPO soon?
No public IPO plans have been announced for Splose.
How can I track Splose secondary market activity?
Caplight tracks bids, offers, and trades in Splose's shares on secondary markets.